**PURPOSE:** Wound healing remains a global issue of disability, cost, and health. Addition of cells from the stromal vascular fraction of adipose tissue have been shown to increase the rate and quality of dermal wound healing. The present study aimed to investigate the angiogenic mechanisms of CD248+ stromal vascular fraction cells in the context of full thickness excisional wounds.

**METHODS:** Single cell transcriptional analysis was used to identify angiogenic gene-expressing ASCs, then correlate with surface marker expression. SVF cells isolated from human lipoaspirate were FACS sorted based on the presence of CD248. Cells were analyzed for gene expression of VEGF and HGF, and subsequently assessed for tubule formation *in vitro.* Following this, 6mm full thickness dermal wounds were created on the dorsa of immunocompromised mice, supplied with a pullalan-collagen hydrogel, and separated into 4 treatment groups; CD248+, CD248-, unsorted SVF, and hydrogel alone. Wounds were measured every other day photometrically until closure. Once fully healed, wounds were harvested for histological analysis through CD31 immunohistochemical staining.

**RESULTS:** Wounds treated with CD248+ cells healed significantly faster than the compared treatment groups. Moreover, immunohistochemistry of CD31 revealed a much higher presence of endothelial cells in the CD248+ group, indicating a large pro-angiogenic effect of CD248+ cells *in vivo.*

**CONCLUSION:** Therefore, using pro-angiogenic cells obtained from SVF presents a viable strategy in wound healing by proxy of increased vessel growth in the wound.
